The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery



Status:Completed
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - 89
Updated:4/21/2016
Start Date:June 2010
End Date:December 2012

Use our guide to learn which trials are right for you!

Arnica montana is a homeopathic drug that is made in accordance with the official methods of
the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic
surgeons throughout the world, although there is no study proving its benefit after
rhinoplasty surgery. The purpose of the research is to see if Arnica montana will reduce the
amount of bruising and the intensity of the bruising after surgery. Photographs of the
subject's face will be taken and used to analyze bruising after rhinoplasty surgery in
subjects who receive Arnica montana and compare them to photographs of subjects who take a
placebo (sugar pill).

Subjects will receive either oral arnica montana or placebo without any identifying labels
or markers on the drugs.

During the post-operative period, the patients will be seen back in surgery clinic on
post-operative days 3, 7 and 10. During the first two visits, the subject will receive
routine post-operative care with no difference from patients not enrolled in the study. This
includes routine sets of photographs. The participant will then return for a third
post-operative visit lasting under ten minutes only for study photos using the left and
right "three-quarters" view. Again, the subject will hold a measurement marker so length
measurements can be made, and this marker will be held under the ear to not interfere with
the routine cosmetic analysis of the photographs. The digital photographs will be used to
analyze the bruising for the study. The ratio was calculated by dividing the number of
pixels of bruised area over number of pixels of standard area.

Inclusion Criteria: Adult patients who are deemed candidates for rhinoplasty surgery at UW
Transformations will be eligible to participate in the study.

Exclusion Criteria:

- Patients who are prisoners

- Patients who are pregnant and breast-feeding women

- Patients taking anti-coagulants (such as blood thinners), anti-platelet drugs (such
as NSAIDS), or other homeopathic remedies during the peri-operative period

- Patients with a bruising or bleeding disorder

- Patients who take oral corticosteroid therapy

- Patients who suffer from severe liver or kidney disease

- Patients with malignancy, infection, immunodeficiency, metabolic syndrome, infectious
or inflammatory gastrointestinal disease

- Patients with oral or contact allergies to Arnica montana or to any other member of
the Asteraceae family of plants such as ragweed, chrysanthemums, marigolds, and
daisies
We found this trial at
1
site
Madison, Wisconsin 53706
(608) 263-2400
University of Wisconsin-Madison In achievement and prestige, the University of Wisconsin-Madison has long been recognized...
?
mi
from
Madison, WI
Click here to add this to my saved trials